Pfizer Press Releases
Breaking News
-
Hear from industry experts at Pain Therapeutics 2012, taking place in 1 week's time
Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK. /EINPresswire.com/ Pain is an incredibly hot topic as it affects all illnesses and all people, in many different ways. This...
-
Look at ways in which companies can develop pain drugs & treatments at Pain Therapeutics 2012
Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK. /EINPresswire.com/ Pain is an incredibly hot topic as it affects all illnesses and all people, in many different ways. This...
-
KOL Management & MSL Best Practice in Europe
/EINPresswire.com/ SMi are proud to present their 4th annual European Conference on KOL Management & MSL Best Practice in Europe, to be held on 2nd & 3rd July 2012 in Basel, Switzerland. The 2012 event will bring together senior Pharma executives...
-
ADMET - Improving predictive models and maximizing drug efficacy
/EINPresswire.com/SMi are proud to present their 7th annual ADMET conference on 9th & 10th July 2012 in London, ADMET studies perform a vital role in the drug discovery process. This conference will address the barriers that are currently faced...
-
6th annual Clinical Trial Logistics Conference
/EINPresswire.com/ SMi present their 6th annual Clinical Trial Logistics event to be held in London on Tuesday 22nd & Wednesday 23rd of May 2012. This event continues a very successful and high quality series which integrates big Pharma and...
Press Releases
Pfizer
-
Royalty Pharma Raises $600 Million of Debt
Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust ("RPIFT"),...
-
Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012
- New vaccine collaborations in infectious diseases and cocaine addiction validate the promise of Immunovaccine's technologies - Successful private placement raises $2.8 million Immunovaccine Inc. (TSX VENTURE:IMV) ("Immunovaccine"...
-
Plan to Speed Up FDA Reviews for New Drugs and Medical Devices Moved to Senate
Five Star Equities Provides Stock Research on Bristol Myers Squibb and Pfizer NEW YORK, NY -- (Marketwire) -- 05/24/12 -- Lost revenues as a result of expiring patents have been a growing problem for the big pharmaceutical companies....
-
Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews
Five Star Equities Provides Stock Research on Merck and Mylan NEW YORK, NY -- (Marketwire) -- 05/24/12 -- Lost revenues as a result of expiring patents have been a growing problem for the big pharmaceutical companies. New products that...
-
Nanosmart(R) Pharmaceuticals Welcomes New Vice President Of R&D
Nanosmart(R) Pharmaceuticals Welcomes New Vice President Of R&D PR Newswire ORANGE COUNTY, Calif. , May 24, 2012 /PRNewswire/ -- Dr. James Smith , President of NanoSmart Pharmaceuticals, Inc., a California corporation...
-
R&D Trends: Depression - Clinical attrition driven by mature market conditions
R&D Trends: Depression - Clinical attrition driven by mature market conditions PR Newswire NEW YORK , May 24, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: R&D...
-
Auxilium Pharmaceuticals, Inc. and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents
Auxilium Pharmaceuticals, Inc. and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents PR Newswire MALVERN, Pa. , and WILMINGTON, Del. , May 24, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals,...
-
New Zoning to Highlight High-Growth Sectors at China Pharma Events
New Zoning to Highlight High-Growth Sectors at China Pharma Events PR Newswire AMSTERDAM , May 23, 2012 /PRNewswire/ -- Leading events organiser UBM Live today announced details of its annual schedule of China events for the global...
-
New Zoning to Highlight High-Growth Sectors at China Pharma Events
New Zoning to Highlight High-Growth Sectors at China Pharma Events PR Newswire AMSTERDAM , May 23, 2012 /PRNewswire/ -- Leading events organiser UBM Live today announced details of its annual schedule of China events for the global...
-
TBWA\London Wins Global Four Seasons Account
TBWA\London Wins Global Four Seasons Account PR Newswire LONDON , May 23, 2012 /PRNewswire-USNewswire/ -- Four Seasons Hotels and Resorts, the premier luxury brand in travel, today named TBWA as its global creative...
-
TraceLink Discusses How the Cloud and Enterprise 2.0 Ensures Supply, Capacity and Quality at ISPE Pharmaceutical Supply Networks Conference
TraceLink Inc., helping businesses securely supply every global market opportunity on-time and in-full with the TraceLink Business Cloud , announced today that Shabbir Dahod, TraceLink's President and CEO, will be speaking at ISPE's Designing,...
-
Research Reports for Morgan Stanley, Pfizer, Duke Energy, Walter Energy, SandRidge Energy, and Fifth Third Bancorp
Research Reports for Morgan Stanley, Pfizer, Duke Energy, Walter Energy, SandRidge Energy, and Fifth Third Bancorp PR Newswire VANCOUVER, British Columbia , May 23, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued...
-
Antibody Drugs: Technologies and Global Markets
Antibody Drugs: Technologies and Global Markets PR Newswire NEW YORK , May 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Antibody Drugs: Technologies and Global...
-
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
Pharmaceuticals - Global Group of Eight (G8) Industry Guide PR Newswire NEW YORK , May 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceuticals - Global...
-
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications PR Newswire NEW YORK , May 23, 2012 /PRNewswire/ -- Reportlinker.com...
Follow us
What people say
Our Partners
© 2005-2012